Medicines Marketed by Biocon Ltd

About Biocon Ltd

Biocon Ltd is a leading biopharmaceutical company founded in 1978 by Kiran Mazumdar-Shaw. Headquartered in Bengaluru, Karnataka, India, Biocon has established a strong global presence, supplying its products to over 120 countries, including major markets such as the United States, Europe, Australia, Canada, and Japan. The company operates across several business segments, including generics, biosimilars, research services, and novel biologics, demonstrating its commitment to making affordable and high-quality therapies accessible worldwide.

Biocon's diverse business verticals showcase its expertise in the research, development, and manufacture of generic active pharmaceutical ingredients (APIs), biosimilars, novel biologics, and the provision of innovative research services. The company's biosimilars segment, managed by Biocon Biologics, focuses on developing and commercialising biosimilar products, including insulins and monoclonal antibodies, to treat various non-communicable diseases such as diabetes, oncology, and immunology.

Biocon Ltd Products

Biocon Ltd manufactures a wide range of pharmaceutical products, including generic APIs, generic formulations, biosimilars, novel biologics, and research and development services. The company's generic APIs are sold in approximately 120 countries and are essential components of various generic medications. Biocon's generic formulations, both branded and unbranded, are used to treat various chronic conditions.

Biocon Biologics has an impressive pipeline of 20 biosimilar assets, with products like rh-insulin, Glargine, and Trastuzumab already commercialised in several key markets.

The company's novel biologics segment focuses on developing and commercialising innovative biologic products, such as Itolizumab for psoriasis and Everolimus for oncology and nephrology. Through its subsidiary Syngene, Biocon offers contract manufacturing, drug licensing, and R&D services for small and large molecules, further expanding its product offerings and capabilities. Biocon Ltd's commitment to quality, affordability, and reliability, coupled with its state-of-the-art manufacturing facilities and adherence to global safety and efficacy standards, ensures that patients worldwide have access to high-quality and life-saving treatments.